Medscape (12/7, Anderson, Subscription Publication) reports, “About 21% of teens newly diagnosed with epilepsy experience suicidal ideation, and the percentage jumps to 31% within 3 years,” according to research presented at the 2022 American Epilepsy Society Annual Meeting. The article adds, “From a cohort of over 400 participants, researchers identified 67 patients aged 11-17 years who were enrolled within 4 months of starting treatment for focal epilepsy.” The team “found that more than 1 in 5 (20.9%) teens endorsed any lifetime SI.”
Related Links:
— Medscape (requires login and subscription)